BOSTON, October 7, 2024 — The Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center is pleased to announce that Brian Reid, a nationally recognized expert in prescription drug policy and communications, is joining the Center as a Senior Fellow.
Reid brings extensive expertise in key areas of drug policy, including drug value assessment, prescription drug pricing, and access. While at CEVR, he will focus on these topics, as well as the implications of the Inflation Reduction Act (IRA) on the pharmaceutical industry and the impact of pharmacy benefit managers (PBMs) on costs and access.
“We are thrilled to have Brian join the CEVR team,” said CEVR Director Peter Neumann. “As readers of his incisive Cost Curve newsletter know, Brian has a unique gift for breaking down the most important trends in pharmaceutical policy in a way that informs the public and policymakers alike – no easy task. We look forward to working with him on our research agenda and helping to communicate our work to policymakers, journalists, and the public.”
“The ability to untangle the complexities of the health care economics is one of the most pressing needs of the next decade, and CEVR has established itself as a critical force in efforts to illuminate and explain how the system operates,” said Reid. “CEVR has exceptional faculty and one-of-a-kind resources, and I look forward to working with those extraordinary individuals and tools to dig into urgent health policy matters, from how the IRA affects the drug development ecosystem to the growing role of PBMs to best practices for communicating the value of prescription drugs.”
Reid is the founder and principal of Reid Strategic, a consulting firm that advises the biopharmaceutical industry and related professions on how to communicate about value, access, price, and reimbursement. He writes the daily Cost Curve newsletter, exploring the intersection between commercial needs, policy realities, and reputational impacts.
Prior to this role, Reid spent three decades as a journalist – covering health policy and health science for Bloomberg News, the Washington Post, and others – and as a public relations professional who built a pioneering value and access group at Real Chemistry, a health care-focused marketing, communication, and advertising firm. Reid has also taught public relations as an adjunct professor at the University of Nebraska-Lincoln.
Reid joins CEVR’s two current Senior Fellows: Melanie Whittington, PhD, formerly Director of Health Economics for the Institute for Clinical Economic Review (ICER), who is an expert on value assessment and economic modeling; and Sean Tunis, MD, MSc, formerly Chief Medical Officer at the Centers for Medicare and Medicaid Services (CMS) a Principal at Rubix Health, who is an expert on the intersection of health technology assessment, regulatory policy, and market access.
About CEVR
CEVR is a national leader on research on the value of health and medical interventions, with the goal of supporting better societal decision-making on health care spending. CEVR is a part of Tufts Medical Center’s Institute for Clinical Research and Health Policy Studies (ICRHPS). We undertake scientific research projects, advance methods development for the field, train the next generation of practitioners and users, and work with policymakers worldwide to develop reasoned policy solutions.
Contact Information
Matt Seidner, Senior Program Manager
